
Genomtec SAZ3.H34Genomtec S.A.Genomtec is an innovative technology company developing a unique mobile point of care (POC) genetic testing platform for the clinical diagnostics market. Its microfluidic lab-on-chip platform uses a patented non-contact heating and detection system and a propriety LAMP based isothermal amplification method for detection of infectious disease pathogens. The company is set to launch its first multiplexed molecular diagnostics assay that can rapidly identify Influenza A/B, RSV A/B, SARS-CoV-2, M.pneumoniae and C.pneumoniae pathogens. Genomtec currently has on the market CE-IVD approved reagents for detection of SARS-CoV-2 directly from Saliva and swab samples for which Genomtec is looking for distributors to help with their international expansion plans. www.genomtec.com